PTC Therapeutics | PTCT - Kapitał Pożyczkowy

Cena Akcji
68.69
Dzienna Zmiana
-2.16 -3.05%
Miesięcznie
4.60%
Rocznie
59.82%
Q2 Prognozy TE
66.81




Kapitał Pożyczkowy Zmiana Data
Acadia Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
BioCryst Pharmaceuticals USD 428.67M 234.31M 2025-12
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Cytokinetics USD 1.12B 957.23M 2025-12
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Enanta Pharmaceuticals USD 0 0 2024-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
Incyte USD 30.2M 5.17M 2025-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 2.03B 193.22M 2025-12
Puma Biotechnology USD 10.87M 222K 2025-06
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
TG Therapeutics USD 245.64M 305K 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Xencor USD 76.48M 11.29M 2025-12